NCT01551329View on ClinicalTrials.gov

Ketamine for Depression and Alcohol Dependence

PHASE1CompletedINTERVENTIONAL
Enrollment

5

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
DepressionAlcohol Dependence
Interventions
DRUG

Ketalar (ketamine)

Intravenous Ketamine 0.5mg/kg

Trial Locations (1)

06516

VA CT Healthcare Systems, West Haven

All Listed Sponsors
collaborator

VA Connecticut Healthcare System

FED

lead

Yale University

OTHER

NCT01551329 - Ketamine for Depression and Alcohol Dependence | Biotech Hunter | Biotech Hunter